Beta adrenoceptor antagonists after myocardial infarction--where are we now?

AUTOR(ES)

Chamberlain, D A

Documentos Relacionados

• MMR: where are we now?
• Digitalis: where are we now?
• Sexually transmitted infections: where are we now?
• Assessment of lupus: where are we now?
• Skeletal palaeopathology and the rheumatic diseases: where are we now?